Physician

Glen W Zuroske, M.D.

According to 2025 Medicare claims, Glen Zuroske, M.D. (NPI: 1891798211) practices cardiology in the Kennewick-Richland, WA market, with the plurality of this provider's patient population coming from Benton, WA. This provider's primary affiliated billing organization is NORTHERN DESERT CARDIOLOGY PC (NPI: 1639351190; TIN: 91-1586490) and primary practice location at 99352-3302. Zuroske is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), Caravan Collaborative Pathways (ACO ID: A4604), and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Zuroske's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,449 traditional Medicare patients, billed 6,174 HCPCS/CPT codes, and received $332,983 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 9,813 prescription claims across 820 beneficiaries totaling $808,260 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 22 claims. Open Payments data shows 4 records totaling $81. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $434,526 to $808,260. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,791	9,526	$451,878
2016	1,909	9,036	$433,961
2017	1,714	8,553	$445,376
2018	1,862	8,245	$437,440
2019	1,241	7,178	$386,587
2020	1,026	5,874	$314,094
2021	1,093	6,066	$390,307
2022	1,450	6,636	$383,051
2023	1,551	6,876	$378,141
2024	1,449	6,174	$332,983

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	613	7,510	$434,526
2016	642	7,693	$442,562
2017	661	7,631	$443,934
2018	685	7,709	$476,075
2019	702	8,078	$537,692
2020	682	8,444	$645,363
2021	692	8,391	$683,886
2022	745	8,753	$768,281
2023	778	9,353	$868,877
2024	820	9,813	$808,260

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	18	$2,448
2016	N/R	21	$1,792
2017	N/R	22	$667
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	810	823	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	473	694	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	869	1,847	$60
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	193	217	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	330	402	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	393	22,537	$430,165
Xarelto	Rivaroxaban	91	5,220	$93,923
Entresto	Sacubitril/Valsartan	88	3,899	$74,239
Farxiga	Dapagliflozin Propanediol	37	1,590	$29,023
Repatha Sureclick	Evolocumab	26	1,128	$22,137

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$81	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Glen W. Zuroske, M.D.?

Tedicare shows public-source Medicare data for Glen W. Zuroske, M.D. (NPI 1891798211), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Glen W. Zuroske, M.D. have ACO affiliation data?

Glen W. Zuroske, M.D. is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342), Caravan Collaborative Pathways (MSSP, ACO ID A4604), and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Glen W. Zuroske, M.D.?

Glen W. Zuroske, M.D. is linked to NORTHERN DESERT CARDIOLOGY PC (billing NPI 1639351190) in the available physician profile data.

Does Glen W. Zuroske, M.D. have Open Payments data?

Glen W. Zuroske, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.